Tazidime and Timolol drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Tazidime (ceftazidime) and Timolol (timolol). Common drug interactions include endophthalmitis among females and drug ineffective among males.

The phase IV clinical study analyzes what interactions people have when they take Tazidime and Timolol. It is created by eHealthMe based on reports of 26 people who take the same drugs from the FDA, and is updated regularly.

What is Tazidime?

Tazidime has active ingredients of ceftazidime. eHealthMe is studying from 10,409 Tazidime users. Check the latest studies of Tazidime.

What is Timolol?

Timolol has active ingredients of timolol. It is often used in glaucoma. eHealthMe is studying from 9,142 Timolol users. Check the latest studies of Timolol.

On Jul, 12, 2026

26 people who take Tazidime and Timolol together, and have interactions are studied.

What are the common drug interactions of Tazidime and Timolol, by gender? *:

female:

Endophthalmitis (inflammation of the internal coats of the eye)
Therapeutic response decreased (less preventive response)
Dyspnoea (difficult or laboured respiration)
Hypoxia (low oxygen in tissues)
Drug ineffective
Cystoid macular oedema (fluid accumulation after cataract surgery)
Blepharitis (chronic inflammation of the eyelid)

male:

Drug ineffective
Drug resistance (reduction in effectiveness of a drug)
Alpha haemolytic streptococcal infection (infections with alpha-haemolytic strep bacteria are common; many strains live naturally in humans)
Arthralgia (joint pain)
Back pain
Osteonecrosis (death of bone)
Osteoporosis (bones weak and more likely to break)

What are the common drug interactions of Tazidime and Timolol, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

Back pain
Osteonecrosis (death of bone)
Osteoporosis (bones weak and more likely to break)
Arthralgia (joint pain)

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

n/a

60+:

Drug ineffective
Drug resistance (reduction in effectiveness of a drug)
Cystoid macular oedema (fluid accumulation after cataract surgery)
Blepharitis (chronic inflammation of the eyelid)
Endophthalmitis (inflammation of the internal coats of the eye)
Therapeutic response decreased (less preventive response)
Alpha haemolytic streptococcal infection (infections with alpha-haemolytic strep bacteria are common; many strains live naturally in humans)
Dyspnoea (difficult or laboured respiration)
Hypoxia (low oxygen in tissues)

What are the existing conditions these people have? *

Endophthalmitis (inflammation of the internal coats of the eye): 17 people, 65.38%
Ulcerative Keratitis (ulcerative inflammation of the cornea): 16 people, 61.54%
Staphylococcal Infection (an infection with staphylococcus bacteria): 16 people, 61.54%
Macular Oedema (fluid and protein deposits collect on or under the macula of the eye (a yellow central area of the retina) and causes it to thicken): 4 people, 15.38%
Depression: 4 people, 15.38%
Uveitis (inflammation of the uvea): 3 people, 11.54%
Pneumonia Viral: 3 people, 11.54%
Intraocular Pressure Increased: 3 people, 11.54%
Dizziness: 3 people, 11.54%
Stress Cardiomyopathy (stress-induced chronic disease of the heart muscle): 2 people, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Tazidime and Timolol?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously